These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2840498)
1. Dimeric 1,4-dihydropyridines as calcium channel antagonists. Joslyn AF; Luchowski E; Triggle DJ J Med Chem; 1988 Aug; 31(8):1489-92. PubMed ID: 2840498 [TBL] [Abstract][Full Text] [Related]
2. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel. Triggle DJ; Janis RA J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383 [TBL] [Abstract][Full Text] [Related]
3. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups]. Soldatov NM Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters. Atwal KS; Bergey JL; Hedberg A; Moreland S J Med Chem; 1987 Apr; 30(4):635-40. PubMed ID: 2435903 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity. Safak C; Sahin I; Sunal R Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450 [TBL] [Abstract][Full Text] [Related]
6. Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers. Rovnyak G; Andersen N; Gougoutas J; Hedberg A; Kimball SD; Malley M; Moreland S; Porubcan M; Pudzianowski A J Med Chem; 1988 May; 31(5):936-44. PubMed ID: 2834556 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent. Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160 [TBL] [Abstract][Full Text] [Related]
8. Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists. Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG J Med Chem; 1990 Feb; 33(2):585-91. PubMed ID: 2153819 [TBL] [Abstract][Full Text] [Related]
9. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers. Campbell KP; Sharp A; Strom M; Kahl SD Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents. Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270 [TBL] [Abstract][Full Text] [Related]
11. Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding. Rovnyak G; Andersen N; Gougoutas J; Hedberg A; Kimball SD; Malley M; Moreland S; Porubcan M; Pudzianowski A J Med Chem; 1991 Aug; 34(8):2521-4. PubMed ID: 1652021 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety. Soboleski DA; Li-Kwong-Ken MC; Wynn H; Triggle CR; Wolowyk MW; Knaus EE Drug Des Deliv; 1988 Feb; 2(3):177-89. PubMed ID: 2855573 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents. Navidpour L; Miri R; Shafiee A Arzneimittelforschung; 2004; 54(9):499-504. PubMed ID: 15500195 [TBL] [Abstract][Full Text] [Related]
18. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone. Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362 [TBL] [Abstract][Full Text] [Related]
19. Comparative studies with enantiomers of dihydropyridine ligands suggests that there are multiple binding sites associated with the calcium channel. O'Neill SK; Bolger GT; Triggle CR Proc West Pharmacol Soc; 1990; 33():235-41. PubMed ID: 1703308 [No Abstract] [Full Text] [Related]
20. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity. Inglesi M; Nicola M; Magnetti S Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]